ALOX5AP and lung carcinoma: Together, we observed distinct immune cell components in the immune microenvironment between both subtypes of lung cancer and identified potential prognostic factors of MARCO, ALOX5AP, and SPP1. We further speculated that the Mφ and lymphocytes were the dominant immune cells that accounted for the differences.